Table 3 Immunohistochemical features of undifferentiated rhabdoid pancreatic carcinomas (n=14)
No | Vimentin | KL-1 | CK7 | EMA | E-cadherin | β-Catenin | TP53 | SMARCB1 IHC |
|---|---|---|---|---|---|---|---|---|
1 | +++ | + | − | − | − | − | − | Intact |
2 | +++ | +++ | ++ | + | − | − | NR | Intact |
3 | +++ | ++ | + | ++ | − | − | NR | Intact |
4 | ++ | +++ | +++ | + | − | − | − | Intact |
5 | +++ | ++ | + | + | − | − | NR | Intact |
6 | +++ | +++ | ++ | ++ | − | + Membranous | − | Intact |
7 | ++ | + | + | + | − | − | 40% | Intact |
8 | +++ | +++ | +++ | ++ | − | − | 20% | Intact |
9 | +++ | ++ | − | − | − | + Membranous | 5% | Intact |
10 | − | +++ | ++ | ++ | − | − | 10% | Intact |
11 | +++ | ++ | − | + | − | − | − | Complete loss |
12 | +++ | +++ | + | + | − | − | NR | Complete loss |
13 | +++ | ++ | − | ++ | − | − | NR | Complete loss |
14 | ++ | +++ | − | +++ | − | ++Cytoplasmic +Membranous | 50% | Complete loss |
